Treace Medical Concepts Inc當前公司基本面數據相對穩定,增長潛力較大。當前估值合理,在醫療設備與耗材行業排名124/207位。機構持股佔比非常高,近一個月多位分析師給出公司評級為持有。最高目標價5.47。中期看,股價處於下降通道。近一個月,市場表現非常差,但基本面評分較高。目前股價在壓力位和支撐位之間,可以做區間波段操作。
Treace Medical Concepts Inc評分
相關信息
行業排名
124 / 207
全市場排名
313 / 4563
所屬行業
醫療設備與耗材
壓力支撐
由於公司未披露,未能獲取相關數據
多維評測
本期評分
上期評分
分析師目標
基於
6
分析師
持有
評級
5.470
目標均價
+109.58%
漲幅空間
數據免責聲明:分析師評級與目標價由LSEG提供,僅供參考,不應當作投資建議
Treace Medical Concepts Inc亮點
亮點風險
Treace Medical Concepts, Inc. is a medical technology company. It is advancing the standard of care for the surgical management of bunion and related midfoot deformities. It has patented the Lapiplasty 3D Bunion Correction System a combination of instruments, implants, and surgical methods designed to surgically correct all three planes of the bunion deformity and secure the unstable joint, addressing the root cause of the bunion and helping patients get back to their active lifestyles. It has Adductoplasty Midfoot Correction System, designed for reproducible surgical correction of midfoot deformities, the SpeedMTP Rapid Compression Implant for addressing bunions through big toe joint fusions, and two systems for minimally invasive osteotomy surgeries: the Nanoplasty 3D Minimally Invasive Bunion Correction System and the Percuplasty Percutaneous 3D Bunion Correction System. It sells its products to physicians, surgeons, ambulatory surgery centers, hospitals, and stocking distributors.
Treace Medical Concepts, Inc. is a medical technology company. It is advancing the standard of care for the surgical management of bunion and related midfoot deformities. It has patented the Lapiplasty 3D Bunion Correction System a combination of instruments, implants, and surgical methods designed to surgically correct all three planes of the bunion deformity and secure the unstable joint, addressing the root cause of the bunion and helping patients get back to their active lifestyles. It has Adductoplasty Midfoot Correction System, designed for reproducible surgical correction of midfoot deformities, the SpeedMTP Rapid Compression Implant for addressing bunions through big toe joint fusions, and two systems for minimally invasive osteotomy surgeries: the Nanoplasty 3D Minimally Invasive Bunion Correction System and the Percuplasty Percutaneous 3D Bunion Correction System. It sells its products to physicians, surgeons, ambulatory surgery centers, hospitals, and stocking distributors.
公司代碼TMCI
公司Treace Medical Concepts Inc
CEOTreace (John T)
網址https://www.treace.com/
常見問題
Treace Medical Concepts Inc(TMCI)的當前股價是多少?
Treace Medical Concepts Inc(TMCI)的當前股價是 2.420。
Treace Medical Concepts Inc 的股票代碼是什麼?
Treace Medical Concepts Inc的股票代碼是TMCI。
Treace Medical Concepts Inc股票的52週最高點是多少?
Treace Medical Concepts Inc股票的52週最高點是10.790。
Treace Medical Concepts Inc股票的52週最低點是多少?
Treace Medical Concepts Inc股票的52週最低點是2.360。
Treace Medical Concepts Inc的市值是多少?
Treace Medical Concepts Inc的市值是154.17M。
Treace Medical Concepts Inc的淨利潤是多少?
Treace Medical Concepts Inc的淨利潤為-55.74M。
現在Treace Medical Concepts Inc(TMCI)的股票是買入、持有還是賣出?
根據分析師評級,Treace Medical Concepts Inc(TMCI)的總體評級為持有,目標價格為5.470。
Treace Medical Concepts Inc(TMCI)股票的每股收益(EPS TTM)是多少
Treace Medical Concepts Inc(TMCI)股票的每股收益(EPS TTM)是-0.794。